Science Explorer Interactive view Map
Company · Utrecht · Netherlands

Merus (Netherlands)

merus.nlROR OpenAlex
Research works
38
▲ 62% vs 2013–17
Citations
697
18.2 per fractional work
Top-10% rate
23.1%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Merus (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.24× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 8.18× its world share, 1 worksImmunology and Micro…Neuroscience: 1.32× its world share, 0 worksNeuroscienceComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringHealth Professions: 1.22× its world share, 0 worksHealth ProfessionsMedicine: 3.11× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.22× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.54× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.13× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.2×. Every wedge is a field page.

Which keywords describe research at Merus (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation10▲ 113×3 topics
  2. Monoclonal Antibodies8▲ 150×3 topics
  3. Therapeutic Antibodies8▲ 157×2 topics
  4. Antibody Engineering7▲ 181×1 topic
  5. Fc Receptors7▲ 181×1 topic
  6. Chemotherapy3▲ 12×8 topics
  7. Monoclonal Antibody3▲ 115×2 topics
  8. Cancer Immunotherapy3▲ 52×2 topics
  9. Breast Cancer3▲ 25×2 topics
  10. Epithelial-Mesenchymal Transition3▲ 82×2 topics
  11. Cancer3▲ 4.8×7 topics
  12. Cancer Stem Cells3▲ 160×1 topic
  13. HER23▲ 222×1 topic
  14. Metastatic3▲ 108×2 topics
  15. Trastuzumab3▲ 157×1 topic
  16. Tumor Metastasis3▲ 114×1 topic
  17. Targeted Therapy2▲ 30×5 topics
  18. Immunotherapy2▲ 9.1×6 topics
  19. Glycans2▲ 68×1 topic
  20. Immune System2▲ 17×1 topic
  21. Cross-Platform Development2▲ 513×1 topic
  22. Mobile Application Development2▲ 513×1 topic
  23. Tumor Regression2▲ 60×2 topics
  24. Tumor Microenvironment2▲ 14×4 topics
  25. Biopharmaceuticals2▲ 63×3 topics
  26. Clinical Trials2▲ 6.6×5 topics
  27. Immunity2▲ 12×3 topics
  28. Antigen Presentation2▲ 39×2 topics
  29. Lymphoma2▲ 26×2 topics
  30. ALK Inhibitors1▲ 67×1 topic
  31. CAR T Cells1▲ 86×1 topic
  32. Chimeric Antigen Receptor1▲ 86×1 topic
  33. EGFR Mutations1▲ 67×1 topic
  34. Innate Immunity1▲ 10×2 topics
  35. Dendritic Cells1▲ 30×1 topic
  36. Immune Checkpoint Blockade1▲ 58×1 topic
  37. Immunogenicity1▲ 67×2 topics
  38. PD-1 and PD-L11▲ 58×1 topic
  39. Tumor Antigen1▲ 43×1 topic
  40. Recombinant Proteins1▲ 57×2 topics

Which research topics does Merus (Netherlands) publish most on?

By volume in 2022–2025: Cancer Cells and Metastasis, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations and Cancer Research and Treatments.

Cancer Cells and Metasta…2Cancer Cells and Metastasis: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksCancer Research and Treatments: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCAR-T cell therapy research: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory MedicineBiotechnology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Cells and Metastasis Oncology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  4. 4 Cancer Research and Treatments Biotechnology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 HER2/EGFR in Cancer Research Oncology 0 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  10. 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.9%not open66.1%

World: 28% of research is openly available.

with international co-authors45.8%domestic only54.2%

World: 19% is written across borders.

How has Merus (Netherlands)'s research output changed?

Output in 2018–2022 was 62% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Utrecht

All research institutions in Utrecht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.